By Dr Anita Mishra, Ritika Gupta
Experts believe that there will be a surge in cases of mental illness in the aftermath of the COVID-19 pandemic due to lasting impact of physical distancing, quarantine and socio-economic factors. According to World Health Organization (WHO),every 40 seconds a person dies by suicide, and it is the second leading cause of deaths in the cohort of 15-29 year-olds. A paper by Indian Council for Medical Research (ICMR) showed thatin 2017, 197 million Indians were suffering from mental disorders of whom 46 million had depressive disorders and 45 million had anxiety disorders. The spread of the novel coronavirus has aggravated the situation. The disease was further declared as air borne, forcing people to limit their movement and physical contact, challenging the survival of humanity. Information through various mediums on the coronavirus is constantly developing fear, stress and anxiety making people often think, say or do what may not be considered ‘ap
Updated Jan 07, 2021 | 16:59 IST
Covaxin is currently undergoing phase 3 trials at multiple locations in India. The phase 3 trials have reached an enrollment of 25,800 volunteers, making it the largest phase 3 trials in the country. Covaxin completes enrolment of 25,800 volunteers as part of largest phase 3 clinical trials in India | Photo Credit: iStock Images
New Delhi: Covaxin phase 3 clinical trials have reached an enrollment of 25,800 volunteers for trials, a statement issued by Bharat Biotech said. Bharat Biotech is the pharma company producing and testing Covaxin, in partnership with the Indian Council for Medical Research. We sincerely express our gratitude to clinical trial sites, Principle Investigators and healthcare workers for their relentless support and trust in our Public-Private Partnership vaccine discovery. My deep appreciation to all the volunteers reposing trust and expressing Pro Vaccine Public Health Volunteerism in t
Threat of mutant Covid strain prompted approval for Covaxin, reveal minutes of SEC meetings
Threat of mutant Covid strain prompted approval for Covaxin, reveal minutes of SEC meetings
Minutes of meetings held between December 30 and January 2 show that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) changed its stance concerning Bharat Biotech s coronavirus vaccine Covaxin.
advertisement
[REPRESENTATIVE IMAGE] (Photo Credits: PTI)
The looming danger of the new mutant strain found in the UK may have turned the odds against Bharat Biotech with respect to its efforts to receive emergency use authorisation for its Covid-19 vaccine Covaxin. India now has 71 cases of the mutant strain with numbers climbing rapidly.
Second Covid-19 vaccine dry run on Friday; health ministers meet tomorrow | Top developments
Second Covid-19 vaccine dry run on Friday; health ministers meet tomorrow | Top developments
The second coronavirus vaccine dry run will be conducted in India on January 8. Meanwhile, Union and state health ministers will hold a virtual meet tomorrow. Here are the top developments.
advertisement
UPDATED: January 7, 2021 06:07 IST
The second dry run of coronavirus vaccine will be carried out in India on Friday, January 8. (File photo: PTI)
Days after conducting the first dry run of coronavirus vaccinations in India on January 2, India is all set to conduct the second such run on January 8. This comes as, on Tuesday, the Government of India announced that the
Advertisement
With India’s drug regulatory authority, the Central Drugs Standard Control Organization (CDSCO), approving emergency use of two coronavirus vaccines, Covishield and Covaxin, the world’s biggest vaccination drive is poised for take-off.
Vaccination of some 300 million frontline health workers, the elderly, and people with co-morbidities is set to begin on January 13. The country has a total population of 1.3 billion.
India is among the countries worst hit by the COVID-19 pandemic. With 10,374,93 coronavirus infections, it has the world’s second largest COVID-19 caseload. While the number of daily infections has been falling in recent weeks, there is concern over new variants of the virus hitting the country.